Search results
Is Moderna Inc (MRNA) Set to Underperform? Analyzing the Factors
Guru Focus· 12 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
The Motley Fool via AOL· 5 days agoA lackluster efficacy profile isn't mResvia's only downside. Abrysvo and Arexvy don't need to stay frozen and can be stored for the long term in the same refrigerator as other traditional < ...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 5 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
AOL· 5 hours agoThe shot, branded Arexvy, as well as vaccines from rivals Pfizer and Moderna are already approved for people aged 60 and older for the indication. RSV, ...
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 5 days agoThe revision follows the approval of Moderna's Respiratory Syncytial Virus (RSV) vaccine by...
First Human Death From Bird Flu Puts Vaccine Stocks On The Map - Moderna (NASDAQ:MRNA), CureVac...
Benzinga· 1 day agoVaccine stocks have been on the fly ever since a never-before-seen bird flu strain started infecting...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation...
KION 46 Salinas· 4 hours agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency...
A New COVID Booster Targeting JN.1 May Arrive This Fall
Verywell Health via Yahoo News· 10 hours agoAn FDA panel voted to recommend an updated COVID-19 vaccine targeting the JN.1 variant. Here's what...
Moderna Investors Just Got Some Bullish News | The Motley Fool
The Motley Fool· 5 days agoModerna (MRNA 3.70%) jumped into the limelight when it started developing a coronavirus vaccine...
The FDA tells COVID-19 vaccine makers to update shot to target newest variant
KSL TV Utah· 2 hours agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency...
